Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus pneumoniae capsular polysaccharide serotype refers to the unique antigenic structure of the capsular polysaccharide that surrounds each Streptococcus pneumoniae bacterium. More than 100 distinct serotypes exist, each defined by the specific sugar composition and linkages in their polysaccharide capsule[3][7][8]. The capsule is the primary virulence factor, protecting the bacterium from phagocytosis by the host immune system and determining its ability to colonize and cause invasive disease[3][4]. Some serotypes are highly associated with invasive pneumococcal disease (IPD), while others are more associated with carriage or non-invasive infections[2]. Serotype identification is critical in epidemiology, vaccine design, and immunology[4][7]. Polysaccharide-based vaccines target the most prevalent or virulent serotypes, but vaccine pressure leads to serotype replacement and shifts in disease epidemiology[1][4][9].
Vaccines induce type-specific antibodies directed against the capsular polysaccharide, leading to opsonization and clearance of the bacteria[1][9]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae capsular polysaccharide serotype.